| Date | Title | Description |
| 19.09.2024 | Navigating the Cyber Frontier: Intel 471's Award-Winning Approach to Cyber Threat Intelligence | In the digital age, threats lurk in every corner of the internet. Cybersecurity is no longer just a tech issue; it’s a business imperative. Organizations must navigate a labyrinth of risks to protect their assets. Enter Intel 471, a beacon ... |
| 18.09.2024 | OM1 Earns Frost & Sullivan's 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms | OM1's innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI integration and highly personalized insights.
SAN ANTONIO, Sept. 18, 2024 /PRNewswire/ -- Frost... |
| 02.10.2023 | OM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand RWE | What You Should Know:
– OM1, a real-world data, AI, and technology company with a focus on chronic diseases launches two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma.
– Both datasets are derived from longitudinal follow-up... |
| 07.09.2023 | OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience | What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.
OM1’s Mental Health & Neuroscience Real-World Data Network, which already... |
| 14.04.2023 | OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine | The digital phenotyping platform, PhenOM, is delivering personalized and actionable healthcare insights around diagnosis, treatment, risk, utilization, and clinical trials
OM1, a leading real-world data, outcomes and technology company with... |
| 13.04.2023 | OM1 Launches AI-Powered Digital Phenotypes Platform, Creating “Fingerprints” for Patients | What You Should Know:
OM1, a real-world data, outcomes and technology company with a focus on chronic conditions, launches PhenOM™, its artificial intelligence-powered platform for personalized medicine.
Calibrated using OM1’s longitudinal ... |
| 26.07.2021 | OM1 Raised $85M, Accion Systems Got $42M, and More Boston Tech News | Photo: OM1
Boston is a bustling scene for healthcare, but companies across a range of other industries are making moves as well. Catch up on the latest news from these innovative startups. This is the Built In Boston weekly refresh.
OM1 sec... |
| 20.07.2021 | OpenSea raises at a $1.5 billion valuation despite an NFT pullback | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Identity security tools can minimize friction for end users From Ping Identity
Few e... |
| 20.07.2021 | OpenSea raises at a $1.5 billion valuation despite an NFT pullback | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Optimizely's CEO on upgrading the marketer experience From Optimizely
Few even in th... |
| 19.07.2021 | OM1 gains $85M to expand clinical data networks, AI models | OM1, a healthcare data and analytics company, raised $85 million in a Series D financing round led by Oakland, California-based Kaiser Permanente, among others.
D1 Capital Partners and Breyer Capital joined Kaiser Permanente in leading the ... |
| 18.07.2021 | OM1 Raises $85M in Funding | OM1, a Boston MA-based health technology company, raised $85M in funding.
The round was led by D1 Capital Partners, Kaiser Permanente, and Breyer Capital, with participation from General Catalyst (GC), Polaris Partners, Scale Venture Partne... |
| 16.07.2021 | OM1 Announces $85M Funding |
BOSTON, MA, OM1, a health technology company, announced an $85 million financing led by D1 Capital Partners, Kaiser Permanente, and Breyer Capital.
>> Click here for more funding data on OM1
>> To export OM1 funding data to ... |
| 14.07.2021 | OM1 Launches Multiple Sclerosis Registry with More than 20,000 Patients Prospectively Followed with Deep Clinical Data | |
| 18.12.2019 | OM1's real-world evidence analytics banks $50M Series C | |
| 18.12.2019 | OM1 Raises $50M to Improve Healthcare With AI | Image via Om1.
OM1, an AI-powered analytics company for the healthcare industry, raised $50 million in its latest funding round.
This Boston-based startup was founded in 2015 by Dr. Richard Gliklich to serve healthcare regulators, payers an... |
| 18.12.2019 | OM1 Closes $50 Million Series C Financing | OM1, a real-world outcomes and technology company, today announced $50 million in Series C financing led by Scale Venture Partners, with participation from existing investors, including General Catalyst (GC), Polaris Partners, and 7wire Ven... |
| 18.12.2019 | OM1 Closes $50M Series C Financing | OM1, a Boston, MA-based real-world outcomes and technology company, closed a $50m Series C financing round.
The round was led by Scale Venture Partners, with participation from existing investors General Catalyst (GC), Polaris Partners, and... |
| 17.12.2019 | Applying big data analytics to patient records, OM1 offers insights to hospitals and pharma | OM1, a big-data analytics company for the healthcare industry, has raised $50 million in its latest round of financing to expand its sales and marketing and product development activities as it brings clinical insights to hospitals and big ... |
| 05.07.2018 | Q2 funding round up: Digital health rakes in over $2B, foreign companies top the charts | |
| 25.05.2018 | Boston Tech Watch: OM1, Tidelift, Notarize, Iboss, Elucidata & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Before everyone checks out for the long weekend, let’s catch up on some recent Boston-area tech news:
—Healthcare technology startup OM1 announced it closed a $21 million Seri... |
| 24.05.2018 | Health outcomes AI company OM1 lands $21M in Series B funding | |
| 24.05.2018 | Term Sheet — Thursday, May 24 | BIG BET
Big news out of the daily fantasy sports world.
Paid Content You can't secure what you can't see From ExtraHop
Under the agreement, Paddy Power will merge its U.S. assets with FanDuel and provide a further $158 million in cash. The ... |
| 23.05.2018 | OM1 Receives $21M Series B |
BOSTON, MA, OM1 today announced that it raised a series B financing round of $21 million.
>> Click here for more funding data on OM1
>> To export OM1 funding data to PDF and Excel, click here
OM1, a leading health outcome... |
| 23.05.2018 | OM1 Raises $21M Series B | OM1, a leading health outcomes and technology company focused on making healthcare more measured, precise and pre-emptive, today announced that it raised a series B financing round of $21 million led by Polaris Partners and with participati... |
| 22.05.2018 | OM1 Closes $21M in Series B Financing | OM1, a Boston, MA-based health outcomes and technology company, raised $21m in Series B financing.
The round was led by Polaris Partners with participation from existing investors General Catalyst (GC) and 7wire Ventures. In conjunction wit... |
| 14.04.2017 | Boston Tech Watch: The Engine, E Ink, GE, OM1, Mobiquity & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
It’s time to catch up on some recent Boston tech headlines:
—The Engine, a new startup accelerator program and investment fund launched by MIT, has raised more than $150 milli... |
| 07.04.2017 | OM1 Raises $15M to Expand Healthcare Outcome Analytics Platform | OM1(formerly known as Better Outcomes), a Boston, MA-based healthcare outcome analytics company has raised $15M in Series A funding led by General Catalyst with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments... |
| 06.04.2017 | Term Sheet — Thursday, April 6 | SOFTWARE AND BREAD
Today’s column is third in a series of interviews with the heads of M&A at the most acquisitive companies in the tech industry. Previously we’ve spoken with dealmakers at Salesforce and Google.
Paid Content Securing t... |
| 06.04.2017 | General Catalyst Leads $15M Series A for OM1 | OM1, a leading healthcare technology company focused on providing outcomes measurement and predictive analytics for value-based and personalized healthcare, today confirmed that it raised a series A financing round of $15 million led by Gen... |
| 06.04.2017 | Exclusive: General Catalyst Leads $15M for Big Data Healthcare Startup | A big data healthcare startup based in Cambridge has come out of stealth mode with a $15 million funding round led by local venture capital firm General Catalyst.
The startup, called OM1, was spun out of General Catalyst by physician Rich G... |
| 06.04.2017 | OM1 Scores $15M |
BOSTON, MA, OM1, a healthcare technology company, raised $15 million in Series A funding.
>> Click here for more funding data on OM1
>> To export OM1 funding data to PDF and Excel, click here
OM1, a leading healthcare tec... |
| 06.04.2017 | OM1 Closes $15M Series A Financing | OM1, a Boston, MA-based healthcare outcome analytics company, closed a $15M Series A financing round.
The round was led by General Catalyst with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments.
The company in... |
| 06.04.2017 | OM1 Raises $15M Series A | OM1, a leading healthcare technology company focused on providing outcomes measurement and predictive analytics for value-based and personalized healthcare, today confirmed that it raised a series A financing round of $15 million led by Gen... |
| - | OM1’s real-world evidence analytics banks $50M Series C | From MobiHealthNews by Dave Muoio |
| - | OM1 gains $85M to expand clinical data networks, AI models | OM1, a healthcare data and analytics company, raised $85 million in a Series D financing round co-led by Oakland, California-based Kaiser Permanente.
D1 Capital Partners and Breyer Capital joined Kaiser Permanente in leading the new funding... |
| - | Real-World Data & Technology Company OM1 Closes $85 Million Financing To Make Healthcare More Measured, Precise, And Pre-Emptive | From PR Newswire |
